Japan Therapeutic Radiopharmaceuticals Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major Region

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report offers an overview of the market trends, drivers, and barriers with respect to the Japan Therapeutic Radiopharmaceuticals market. It also provides a detailed overview of the market of different regions across Hokkaido, Tohoku, Kanto, Chubu, Kinki, Chugoku, Shikoku, Kyushu. The report deep analyzes type and application in Japan Therapeutic Radiopharmaceuticals market. Detailed analysis of key players, along with key growth strategies adopted by Therapeutic Radiopharmaceuticals industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Spectrum Pharmaceuticals

    • Curium Pharmaceuticals

    • International Isotopes

    • Bayer

    • Progenics Pharmaceuticals

    • Jubilant DraxImage

    • Q BioMed

    • Lantheus

    • Novartis

    • China Isotope & Radiation

    • Dongcheng

    By Type:

    • Radium-223

    • Lutetium-177

    • Iodine-131

    • Other

    By End-User:

    • Thyroid

    • Bone Metastasis

    • Lymphoma

    • Other

    By Region:

    • Hokkaido

    • Tohoku

    • Kanto

    • Chubu

    • Kinki

    • Chugoku

    • Shikoku

    • Kyushu

  • 1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Therapeutic Radiopharmaceuticals Market

    • 1.3 Market Segment by Type

      • 1.3.1 Japan Therapeutic Radiopharmaceuticals Market Size and Growth Rate of Radium-223 from 2014 to 2026

      • 1.3.2 Japan Therapeutic Radiopharmaceuticals Market Size and Growth Rate of Lutetium-177 from 2014 to 2026

      • 1.3.3 Japan Therapeutic Radiopharmaceuticals Market Size and Growth Rate of Iodine-131 from 2014 to 2026

      • 1.3.4 Japan Therapeutic Radiopharmaceuticals Market Size and Growth Rate of Other from 2014 to 2026

    • 1.4 Market Segment by Application

      • 1.4.1 Japan Therapeutic Radiopharmaceuticals Market Size and Growth Rate of Thyroid from 2014 to 2026

      • 1.4.2 Japan Therapeutic Radiopharmaceuticals Market Size and Growth Rate of Bone Metastasis from 2014 to 2026

      • 1.4.3 Japan Therapeutic Radiopharmaceuticals Market Size and Growth Rate of Lymphoma from 2014 to 2026

      • 1.4.4 Japan Therapeutic Radiopharmaceuticals Market Size and Growth Rate of Other from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Hokkaido Therapeutic Radiopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Tohoku Therapeutic Radiopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Kanto Therapeutic Radiopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Chubu Therapeutic Radiopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Kinki Therapeutic Radiopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Chugoku Therapeutic Radiopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Shikoku Therapeutic Radiopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Kyushu Therapeutic Radiopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Therapeutic Radiopharmaceuticals Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Therapeutic Radiopharmaceuticals by Major Types

      • 3.4.1 Market Size and Growth Rate of Radium-223

      • 3.4.2 Market Size and Growth Rate of Lutetium-177

      • 3.4.3 Market Size and Growth Rate of Iodine-131

      • 3.4.4 Market Size and Growth Rate of Other

    4 Segmentation of Therapeutic Radiopharmaceuticals Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Therapeutic Radiopharmaceuticals by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Therapeutic Radiopharmaceuticals in Thyroid

      • 4.4.2 Market Size and Growth Rate of Therapeutic Radiopharmaceuticals in Bone Metastasis

      • 4.4.3 Market Size and Growth Rate of Therapeutic Radiopharmaceuticals in Lymphoma

      • 4.4.4 Market Size and Growth Rate of Therapeutic Radiopharmaceuticals in Other

    5 Market Analysis by Regions

    • 5.1 Japan Therapeutic Radiopharmaceuticals Production Analysis by Regions

    • 5.2 Japan Therapeutic Radiopharmaceuticals Consumption Analysis by Regions

    6 Hokkaido Therapeutic Radiopharmaceuticals Landscape Analysis

    • 6.1 Hokkaido Therapeutic Radiopharmaceuticals Landscape Analysis by Major Types

    • 6.2 Hokkaido Therapeutic Radiopharmaceuticals Landscape Analysis by Major End-Users

    7 Tohoku Therapeutic Radiopharmaceuticals Landscape Analysis

    • 7.1 Tohoku Therapeutic Radiopharmaceuticals Landscape Analysis by Major Types

    • 7.2 Tohoku Therapeutic Radiopharmaceuticals Landscape Analysis by Major End-Users

    8 Kanto Therapeutic Radiopharmaceuticals Landscape Analysis

    • 8.1 Kanto Therapeutic Radiopharmaceuticals Landscape Analysis by Major Types

    • 8.2 Kanto Therapeutic Radiopharmaceuticals Landscape Analysis by Major End-Users

    9 Chubu Therapeutic Radiopharmaceuticals Landscape Analysis

    • 9.1 Chubu Therapeutic Radiopharmaceuticals Landscape Analysis by Major Types

    • 9.2 Chubu Therapeutic Radiopharmaceuticals Landscape Analysis by Major End-Users

    10 Kinki Therapeutic Radiopharmaceuticals Landscape Analysis

    • 10.1 Kinki Therapeutic Radiopharmaceuticals Landscape Analysis by Major Types

    • 10.2 Kinki Therapeutic Radiopharmaceuticals Landscape Analysis by Major End-Users

    11 Chugoku Therapeutic Radiopharmaceuticals Landscape Analysis

    • 11.1 Chugoku Therapeutic Radiopharmaceuticals Landscape Analysis by Major Types

    • 11.2 Chugoku Therapeutic Radiopharmaceuticals Landscape Analysis by Major End-Users

    12 Shikoku Therapeutic Radiopharmaceuticals Landscape Analysis

    • 12.1 Shikoku Therapeutic Radiopharmaceuticals Landscape Analysis by Major Types

    • 12.2 Shikoku Therapeutic Radiopharmaceuticals Landscape Analysis by Major End-Users

    13 Kyushu Therapeutic Radiopharmaceuticals Landscape Analysis

    • 13.1 Kyushu Therapeutic Radiopharmaceuticals Landscape Analysis by Major Types

    • 13.2 Kyushu Therapeutic Radiopharmaceuticals Landscape Analysis by Major End-Users

    14 Major Players Profiles

    • 14.1 Spectrum Pharmaceuticals

      • 14.1.1 Spectrum Pharmaceuticals Company Profile and Recent Development

      • 14.1.2 Market Performance

      • 14.1.3 Product and Service Introduction

    • 14.2 Curium Pharmaceuticals

      • 14.2.1 Curium Pharmaceuticals Company Profile and Recent Development

      • 14.2.2 Market Performance

      • 14.2.3 Product and Service Introduction

    • 14.3 International Isotopes

      • 14.3.1 International Isotopes Company Profile and Recent Development

      • 14.3.2 Market Performance

      • 14.3.3 Product and Service Introduction

    • 14.4 Bayer

      • 14.4.1 Bayer Company Profile and Recent Development

      • 14.4.2 Market Performance

      • 14.4.3 Product and Service Introduction

    • 14.5 Progenics Pharmaceuticals

      • 14.5.1 Progenics Pharmaceuticals Company Profile and Recent Development

      • 14.5.2 Market Performance

      • 14.5.3 Product and Service Introduction

    • 14.6 Jubilant DraxImage

      • 14.6.1 Jubilant DraxImage Company Profile and Recent Development

      • 14.6.2 Market Performance

      • 14.6.3 Product and Service Introduction

    • 14.7 Q BioMed

      • 14.7.1 Q BioMed Company Profile and Recent Development

      • 14.7.2 Market Performance

      • 14.7.3 Product and Service Introduction

    • 14.8 Lantheus

      • 14.8.1 Lantheus Company Profile and Recent Development

      • 14.8.2 Market Performance

      • 14.8.3 Product and Service Introduction

    • 14.9 Novartis

      • 14.9.1 Novartis Company Profile and Recent Development

      • 14.9.2 Market Performance

      • 14.9.3 Product and Service Introduction

    • 14.10 China Isotope & Radiation

      • 14.10.1 China Isotope & Radiation Company Profile and Recent Development

      • 14.10.2 Market Performance

      • 14.10.3 Product and Service Introduction

    • 14.11 Dongcheng

      • 14.11.1 Dongcheng Company Profile and Recent Development

      • 14.11.2 Market Performance

      • 14.11.3 Product and Service Introduction

     

    The List of Tables and Figures (Totals 135 Figures and 175 Tables)

    • Figure Japan Therapeutic Radiopharmaceuticals Market Size and Growth Rate of Radium-223 from 2014 to 2026

    • Figure Japan Therapeutic Radiopharmaceuticals Market Size and Growth Rate of Lutetium-177 from 2014 to 2026

    • Figure Japan Therapeutic Radiopharmaceuticals Market Size and Growth Rate of Iodine-131 from 2014 to 2026

    • Figure Japan Therapeutic Radiopharmaceuticals Market Size and Growth Rate of Other from 2014 to 2026

    • Figure Market Share by Type in 2014

    • Figure Market Share by Type in 2018

    • Figure Market Share by Type in 2026

    • Figure Japan Therapeutic Radiopharmaceuticals Market Size and Growth Rate of Thyroid from 2014 to 2026

    • Figure Japan Therapeutic Radiopharmaceuticals Market Size and Growth Rate of Bone Metastasis from 2014 to 2026

    • Figure Japan Therapeutic Radiopharmaceuticals Market Size and Growth Rate of Lymphoma from 2014 to 2026

    • Figure Japan Therapeutic Radiopharmaceuticals Market Size and Growth Rate of Other from 2014 to 2026

    • Figure Market Share by End-User in 2014

    • Figure Market Share by End-User in 2018

    • Figure Market Share by End-User in 2026

    • Figure Hokkaido Therapeutic Radiopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Tohoku Therapeutic Radiopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kanto Therapeutic Radiopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Chubu Therapeutic Radiopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kinki Therapeutic Radiopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Chugoku Therapeutic Radiopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Shikoku Therapeutic Radiopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kyushu Therapeutic Radiopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Therapeutic Radiopharmaceuticals Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2018

    • Figure Market Share of TOP 5 Players in 2018

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Therapeutic Radiopharmaceuticals

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Therapeutic Radiopharmaceuticals by Different Types from 2014 to 2026

    • Table Consumption Share of Therapeutic Radiopharmaceuticals by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Radium-223

    • Figure Market Size and Growth Rate of Lutetium-177

    • Figure Market Size and Growth Rate of Iodine-131

    • Figure Market Size and Growth Rate of Other

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Therapeutic Radiopharmaceuticals by Different End-Users from 2014 to 2026

    • Table Consumption Share of Therapeutic Radiopharmaceuticals by Different End-Users from 2014 to 2026

    • Figure Japan Therapeutic Radiopharmaceuticals Market Size and Growth Rate of Thyroid from 2014 to 2026

    • Figure Japan Therapeutic Radiopharmaceuticals Market Size and Growth Rate of Bone Metastasis from 2014 to 2026

    • Figure Japan Therapeutic Radiopharmaceuticals Market Size and Growth Rate of Lymphoma from 2014 to 2026

    • Figure Japan Therapeutic Radiopharmaceuticals Market Size and Growth Rate of Other from 2014 to 2026

    • Table Japan Therapeutic Radiopharmaceuticals Production by Regions

    • Table Japan Therapeutic Radiopharmaceuticals Production Share by Regions

    • Figure Japan Therapeutic Radiopharmaceuticals Production Share by Regions in 2014

    • Figure Japan Therapeutic Radiopharmaceuticals Production Share by Regions in 2018

    • Figure Japan Therapeutic Radiopharmaceuticals Production Share by Regions in 2026

    • Table Japan Therapeutic Radiopharmaceuticals Consumption by Regions

    • Table Japan Therapeutic Radiopharmaceuticals Consumption Share by Regions

    • Figure Japan Therapeutic Radiopharmaceuticals Consumption Share by Regions in 2014

    • Figure Japan Therapeutic Radiopharmaceuticals Consumption Share by Regions in 2018

    • Figure Japan Therapeutic Radiopharmaceuticals Consumption Share by Regions in 2026

    • Table Hokkaido Therapeutic Radiopharmaceuticals Consumption by Types from 2014 to 2026

    • Table Hokkaido Therapeutic Radiopharmaceuticals Consumption Share by Types from 2014 to 2026

    • Figure Hokkaido Therapeutic Radiopharmaceuticals Consumption Share by Types in 2014

    • Figure Hokkaido Therapeutic Radiopharmaceuticals Consumption Share by Types in 2018

    • Figure Hokkaido Therapeutic Radiopharmaceuticals Consumption Share by Types in 2026

    • Table Hokkaido Therapeutic Radiopharmaceuticals Consumption by End-Users from 2014 to 2026

    • Table Hokkaido Therapeutic Radiopharmaceuticals Consumption Share by End-Users from 2014 to 2026

    • Figure Hokkaido Therapeutic Radiopharmaceuticals Consumption Share by End-Users in 2014

    • Figure Hokkaido Therapeutic Radiopharmaceuticals Consumption Share by End-Users in 2018

    • Figure Hokkaido Therapeutic Radiopharmaceuticals Consumption Share by End-Users in 2026

    • Table Tohoku Therapeutic Radiopharmaceuticals Consumption by Types from 2014 to 2026

    • Table Tohoku Therapeutic Radiopharmaceuticals Consumption Share by Types from 2014 to 2026

    • Figure Tohoku Therapeutic Radiopharmaceuticals Consumption Share by Types in 2014

    • Figure Tohoku Therapeutic Radiopharmaceuticals Consumption Share by Types in 2018

    • Figure Tohoku Therapeutic Radiopharmaceuticals Consumption Share by Types in 2026

    • Table Tohoku Therapeutic Radiopharmaceuticals Consumption by End-Users from 2014 to 2026

    • Table Tohoku Therapeutic Radiopharmaceuticals Consumption Share by End-Users from 2014 to 2026

    • Figure Tohoku Therapeutic Radiopharmaceuticals Consumption Share by End-Users in 2014

    • Figure Tohoku Therapeutic Radiopharmaceuticals Consumption Share by End-Users in 2018

    • Figure Tohoku Therapeutic Radiopharmaceuticals Consumption Share by End-Users in 2026

    • Table Kanto Therapeutic Radiopharmaceuticals Consumption by Types from 2014 to 2026

    • Table Kanto Therapeutic Radiopharmaceuticals Consumption Share by Types from 2014 to 2026

    • Figure Kanto Therapeutic Radiopharmaceuticals Consumption Share by Types in 2014

    • Figure Kanto Therapeutic Radiopharmaceuticals Consumption Share by Types in 2018

    • Figure Kanto Therapeutic Radiopharmaceuticals Consumption Share by Types in 2026

    • Table Kanto Therapeutic Radiopharmaceuticals Consumption by End-Users from 2014 to 2026

    • Table Kanto Therapeutic Radiopharmaceuticals Consumption Share by End-Users from 2014 to 2026

    • Figure Kanto Therapeutic Radiopharmaceuticals Consumption Share by End-Users in 2014

    • Figure Kanto Therapeutic Radiopharmaceuticals Consumption Share by End-Users in 2018

    • Figure Kanto Therapeutic Radiopharmaceuticals Consumption Share by End-Users in 2026

    • Table Chubu Therapeutic Radiopharmaceuticals Consumption by Types from 2014 to 2026

    • Table Chubu Therapeutic Radiopharmaceuticals Consumption Share by Types from 2014 to 2026

    • Figure Chubu Therapeutic Radiopharmaceuticals Consumption Share by Types in 2014

    • Figure Chubu Therapeutic Radiopharmaceuticals Consumption Share by Types in 2018

    • Figure Chubu Therapeutic Radiopharmaceuticals Consumption Share by Types in 2026

    • Table Chubu Therapeutic Radiopharmaceuticals Consumption by End-Users from 2014 to 2026

    • Table Chubu Therapeutic Radiopharmaceuticals Consumption Share by End-Users from 2014 to 2026

    • Figure Chubu Therapeutic Radiopharmaceuticals Consumption Share by End-Users in 2014

    • Figure Chubu Therapeutic Radiopharmaceuticals Consumption Share by End-Users in 2018

    • Figure Chubu Therapeutic Radiopharmaceuticals Consumption Share by End-Users in 2026

    • Table Kinki Therapeutic Radiopharmaceuticals Consumption by Types from 2014 to 2026

    • Table Kinki Therapeutic Radiopharmaceuticals Consumption Share by Types from 2014 to 2026

    • Figure Kinki Therapeutic Radiopharmaceuticals Consumption Share by Types in 2014

    • Figure Kinki Therapeutic Radiopharmaceuticals Consumption Share by Types in 2018

    • Figure Kinki Therapeutic Radiopharmaceuticals Consumption Share by Types in 2026

    • Table Kinki Therapeutic Radiopharmaceuticals Consumption by End-Users from 2014 to 2026

    • Table Kinki Therapeutic Radiopharmaceuticals Consumption Share by End-Users from 2014 to 2026

    • Figure Kinki Therapeutic Radiopharmaceuticals Consumption Share by End-Users in 2014

    • Figure Kinki Therapeutic Radiopharmaceuticals Consumption Share by End-Users in 2018

    • Figure Kinki Therapeutic Radiopharmaceuticals Consumption Share by End-Users in 2026

    • Table Chugoku Therapeutic Radiopharmaceuticals Consumption by Types from 2014 to 2026

    • Table Chugoku Therapeutic Radiopharmaceuticals Consumption Share by Types from 2014 to 2026

    • Figure Chugoku Therapeutic Radiopharmaceuticals Consumption Share by Types in 2014

    • Figure Chugoku Therapeutic Radiopharmaceuticals Consumption Share by Types in 2018

    • Figure Chugoku Therapeutic Radiopharmaceuticals Consumption Share by Types in 2026

    • Table Chugoku Therapeutic Radiopharmaceuticals Consumption by End-Users from 2014 to 2026

    • Table Chugoku Therapeutic Radiopharmaceuticals Consumption Share by End-Users from 2014 to 2026

    • Figure Chugoku Therapeutic Radiopharmaceuticals Consumption Share by End-Users in 2014

    • Figure Chugoku Therapeutic Radiopharmaceuticals Consumption Share by End-Users in 2018

    • Figure Chugoku Therapeutic Radiopharmaceuticals Consumption Share by End-Users in 2026

    • Table Shikoku Therapeutic Radiopharmaceuticals Consumption by Types from 2014 to 2026

    • Table Shikoku Therapeutic Radiopharmaceuticals Consumption Share by Types from 2014 to 2026

    • Figure Shikoku Therapeutic Radiopharmaceuticals Consumption Share by Types in 2014

    • Figure Shikoku Therapeutic Radiopharmaceuticals Consumption Share by Types in 2018

    • Figure Shikoku Therapeutic Radiopharmaceuticals Consumption Share by Types in 2026

    • Table Shikoku Therapeutic Radiopharmaceuticals Consumption by End-Users from 2014 to 2026

    • Table Shikoku Therapeutic Radiopharmaceuticals Consumption Share by End-Users from 2014 to 2026

    • Figure Shikoku Therapeutic Radiopharmaceuticals Consumption Share by End-Users in 2014

    • Figure Shikoku Therapeutic Radiopharmaceuticals Consumption Share by End-Users in 2018

    • Figure Shikoku Therapeutic Radiopharmaceuticals Consumption Share by End-Users in 2026

    • Table Kyushu Therapeutic Radiopharmaceuticals Consumption by Types from 2014 to 2026

    • Table Kyushu Therapeutic Radiopharmaceuticals Consumption Share by Types from 2014 to 2026

    • Figure Kyushu Therapeutic Radiopharmaceuticals Consumption Share by Types in 2014

    • Figure Kyushu Therapeutic Radiopharmaceuticals Consumption Share by Types in 2018

    • Figure Kyushu Therapeutic Radiopharmaceuticals Consumption Share by Types in 2026

    • Table Kyushu Therapeutic Radiopharmaceuticals Consumption by End-Users from 2014 to 2026

    • Table Kyushu Therapeutic Radiopharmaceuticals Consumption Share by End-Users from 2014 to 2026

    • Figure Kyushu Therapeutic Radiopharmaceuticals Consumption Share by End-Users in 2014

    • Figure Kyushu Therapeutic Radiopharmaceuticals Consumption Share by End-Users in 2018

    • Figure Kyushu Therapeutic Radiopharmaceuticals Consumption Share by End-Users in 2026

    • Table Company Profile and Development Status of Spectrum Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Spectrum Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Spectrum Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Spectrum Pharmaceuticals

    • Table Product and Service Introduction of Spectrum Pharmaceuticals

    • Table Company Profile and Development Status of Curium Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Curium Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Curium Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Curium Pharmaceuticals

    • Table Product and Service Introduction of Curium Pharmaceuticals

    • Table Company Profile and Development Status of International Isotopes

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of International Isotopes

    • Figure Sales and Growth Rate Analysis of International Isotopes

    • Figure Revenue and Market Share Analysis of International Isotopes

    • Table Product and Service Introduction of International Isotopes

    • Table Company Profile and Development Status of Bayer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer

    • Figure Sales and Growth Rate Analysis of Bayer

    • Figure Revenue and Market Share Analysis of Bayer

    • Table Product and Service Introduction of Bayer

    • Table Company Profile and Development Status of Progenics Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Progenics Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Progenics Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Progenics Pharmaceuticals

    • Table Product and Service Introduction of Progenics Pharmaceuticals

    • Table Company Profile and Development Status of Jubilant DraxImage

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Jubilant DraxImage

    • Figure Sales and Growth Rate Analysis of Jubilant DraxImage

    • Figure Revenue and Market Share Analysis of Jubilant DraxImage

    • Table Product and Service Introduction of Jubilant DraxImage

    • Table Company Profile and Development Status of Q BioMed

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Q BioMed

    • Figure Sales and Growth Rate Analysis of Q BioMed

    • Figure Revenue and Market Share Analysis of Q BioMed

    • Table Product and Service Introduction of Q BioMed

    • Table Company Profile and Development Status of Lantheus

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Lantheus

    • Figure Sales and Growth Rate Analysis of Lantheus

    • Figure Revenue and Market Share Analysis of Lantheus

    • Table Product and Service Introduction of Lantheus

    • Table Company Profile and Development Status of Novartis

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis

    • Figure Sales and Growth Rate Analysis of Novartis

    • Figure Revenue and Market Share Analysis of Novartis

    • Table Product and Service Introduction of Novartis

    • Table Company Profile and Development Status of China Isotope & Radiation

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of China Isotope & Radiation

    • Figure Sales and Growth Rate Analysis of China Isotope & Radiation

    • Figure Revenue and Market Share Analysis of China Isotope & Radiation

    • Table Product and Service Introduction of China Isotope & Radiation

    • Table Company Profile and Development Status of Dongcheng

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Dongcheng

    • Figure Sales and Growth Rate Analysis of Dongcheng

    • Figure Revenue and Market Share Analysis of Dongcheng

    • Table Product and Service Introduction of Dongcheng

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.